Chevance L G, Causse J R, Bergès J
Arch Otolaryngol. 1976 Jun;102(6):363-4. doi: 10.1001/archotol.1976.00780110075008.
Previous studies by the Adams method demonstrated a strong correlation between hydrolytic enzyme activity of perilymph and progression of bone conduction loss two years preceding stapedectomy. Alpha 1-Antitrypsin was chosen since its activity can be very precisely measured by a radical immunodiffusion technique and since it is one of the enzymes identified in perilymph of patients with active otospongiosis. Samples of 3 mul to 5 mul of perilymph removed during 103 stapedectomies and samples of known alpha 1-trypsin activity were placed on slides coated with alpha 1-antitrypsin serum. The zone of diffusion was stained and measured after 38 hours of incubation. Antitrypsin values were lowest in 24 cases, two with no preoperative bone conduction progression, three with moderate progression of 10 to 15 dB, and 19 with rapid progression of more than 20 dB. They were highest in 36 cases with no progression, and in one case with moderate progression. This study confirms previous reports on the enzymatic activity in otospongiotic disease.
亚当斯方法先前的研究表明,在前庭淋巴水解酶活性与镫骨切除术两年前骨传导损失进展之间存在很强的相关性。之所以选择α1-抗胰蛋白酶,是因为其活性可以通过放射免疫扩散技术非常精确地测量,而且它是在活动性耳硬化症患者的前庭淋巴中发现的酶之一。在103例镫骨切除术中取出的3微升至5微升前庭淋巴样本以及已知α1-胰蛋白酶活性的样本,被放置在涂有α1-抗胰蛋白酶血清的载玻片上。孵育38小时后,对扩散区域进行染色和测量。抗胰蛋白酶值在24例中最低,其中2例术前骨传导无进展,3例骨传导中度进展10至15分贝,19例骨传导快速进展超过20分贝。在36例无进展以及1例中度进展的病例中,抗胰蛋白酶值最高。本研究证实了先前关于耳硬化症疾病中酶活性的报道。